127958-79-6

Downstream Products

• 141949-60-2 (1'S,2'S)-Dibenzyl-N-<2-(2'-acetylaminocyclohexyloxy)acetyl>-L-alanyl-D-glutamate 
• 141949-60-2 (1'R,2'R)-Dibenzyl-N-<2-(2'-acetylaminocyclohexyloxy)acetyl>-L-alanyl-D-glutamate 
• 141949-62-4 (1'R,2'R)-Benzyl-N-<2-(2'-acetylaminocyclohexyloxy)acetyl>-L-alanyl-D-isoglutaminate 
• 141949-62-4 (1'S,2'S)-Benzyl-N-<2-(2'-acetylaminocyclohexyloxy)acetyl>-L-alanyl-D-isoglutaminate 
• 141949-61-3 (1'R,2'R)-N-<2-(2'-Acetylaminocyclohexyloxy)acetyl>-L-alanyl-D-glutamic acid 
• 141949-61-3 (1'S,2'S)-N-<2-(2'-Acetylaminocyclohexyloxy)acetyl>-L-alanyl-D-glutamic acid 
• 141949-63-5 (1'R,2'R)-N-<2-(2'-Acetylaminocyclohexyloxy)acetyl>-L-alanyl-D-isoglutamine 
• 141949-63-5 (1'S,2'S)-N-<2-(2'-Acetylaminocyclohexyloxy)acetyl>-L-alanyl-D-isoglutamine 
• 134961-98-1 trans-2-(2'-acetylaminocyclohexyloxy)acetic acid 

Relevant academic research and scientific papers

Preparation of diastereomerically pure immunologically active carbocyclic nor-muramyldipeptide analogues

The preparation of diastereomerically pure immunologically active carbocyclic nor-muramyldipeptide analogues (1'R,2'R)-/(1'S,2'S)-N-[2-(2'-acetylaminocyclohexyloxy)acetyl]-L- alanyl-D-isoglutamine and (1'R,2'R)-/(1'S,2'S)-N-[2-(2'-acetylaminocyclohexyloxy)acetyl]-L- alanyl-D-glutamic acid is described. The title compounds were synthesized using two independent synthetic routes from racemic trans-2-azidocyclohexanol and (1R,2R)-/(1S,2S)-2-aminocyclohexanol, respectively.

Diphosphonic acid compounds and use for calcium metabolism disorders

The present invention provides compounds of the formula: STR1 The present invention also provides processes for the preparation of these compounds and pharmaceutical compositions containing them useful in treatment and prophylaxis of disorders of calcium metabolism.